or Try an Advanced Search...

    Technical Analysis for VSTM - Verastem, Inc.

    Grade Last Price % Change Price Change
    F 3.25 9.06% 0.27
    VSTM closed up 9.06 percent on Monday, July 1, 2024, on 89 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Up
    Historical VSTM trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Pocket Pivot Bullish Swing Setup 9.06%
    Volume Surge Other 9.06%
    Narrow Range Bar Range Contraction 9.06%
    Wide Bands Range Expansion 9.06%
    Oversold Stochastic Weakness 9.06%
    New 52 Week Closing Low Bearish 12.07%
    180 Bearish Setup Bearish Swing Setup 12.07%
    Wide Bands Range Expansion 12.07%
    Older End-of-Day Signals for VSTM ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above 10 DMA about 10 hours ago
    1.5x Volume Pace about 10 hours ago
    10 DMA Resistance about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    VSTM Chart by TradingView
    Basic chart:

    Profile

    Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Oncology Stem Cell Breast Cancer Ovarian Cancer Treatment Of Breast Cancer Signal Transduction Cancer Research mTOR Companion Diagnostic Metastasis Advanced Cancer Mesothelioma Advanced Cancers Cancer Stem Cell Cancer Stem Cells Mtor Inhibitors

    Is VSTM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes
    Jun 10 Verastem: Market Overreaction Creates A Dip Buying Opportunity
    Jun 6 7 F-Rated Stocks to Avoid at All Costs in June
    May 30 Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
    May 26 Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
    May 26 Verastem: Narrowed Market And Less Compelling Efficacy Warrant Rating Downgrade
    May 24 Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
    May 24 What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
    May 24 Sector Update: Health Care Stocks Advance Pre-Bell Friday
    May 24 ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
    See more VSTM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.22
    52 Week Low 2.8
    Average Volume 943,325
    200-Day Moving Average 8.96
    50-Day Moving Average 7.27
    20-Day Moving Average 3.37
    10-Day Moving Average 3.14
    Average True Range 0.40
    RSI (14) 29.58
    ADX 50.88
    +DI 16.06
    -DI 41.53
    Chandelier Exit (Long, 3 ATRs) 2.93
    Chandelier Exit (Short, 3 ATRs) 4.00
    Upper Bollinger Bands 3.94
    Lower Bollinger Band 2.80
    Percent B (%b) 0.4
    BandWidth 33.90
    MACD Line -1.20
    MACD Signal Line -1.44
    MACD Histogram 0.2455
    Fundamentals Value
    Market Cap 82.12 Million
    Num Shares 25.3 Million
    EPS -3.89
    Price-to-Earnings (P/E) Ratio -0.84
    Price-to-Sales 51.84
    Price-to-Book 4.01
    PEG Ratio -1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.70
    Resistance 3 (R3) 3.66 3.47 3.63
    Resistance 2 (R2) 3.47 3.36 3.49 3.60
    Resistance 1 (R1) 3.36 3.28 3.42 3.40 3.57
    Pivot Point 3.17 3.17 3.20 3.19 3.17
    Support 1 (S1) 3.06 3.06 3.12 3.10 2.93
    Support 2 (S2) 2.87 2.98 2.89 2.90
    Support 3 (S3) 2.76 2.87 2.88
    Support 4 (S4) 2.80